What price per share was used for Ellis Gary Lee’s Inspire Medical Systems (INSP) stock grant?

The stock grant to Ellis Gary Lee used a value of $52.07 per share. This price is shown in the Form 4 as the transaction price per share for the 518 Common Stock shares granted under the company’s Non-Employee Director Compensation Policy.

Director Ellis receives 518 Inspire Medical (INSP) shares as fees

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Ellis Gary Lee reported acquisition or exercise transactions in this Form 4 filing.

Inspire Medical Systems director Ellis Gary Lee received 518 shares of Common Stock as a stock award. The shares were granted at a value of $52.07 per share and were received in lieu of cash fees under the company’s Non-Employee Director Compensation Policy. Following this award, Lee directly holds 7,276 shares of Inspire Medical Systems common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Ellis Gary Lee

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	518	$52.07	$27K

Holdings After Transaction: Common Stock — 7,276 shares (Direct)

Footnotes (1)

[object Object]

Key Figures

Stock grant size: 518 shares Grant value per share: $52.07 per share Shares held after grant: 7,276 shares +2 more

5 metrics

Stock grant size 518 shares Common Stock awarded to director Ellis Gary Lee

Grant value per share $52.07 per share Value used for the 518-share stock award

Shares held after grant 7,276 shares Total direct Common Stock holdings post-transaction

Transaction code A Grant, award, or other acquisition of Common Stock

Transaction date 2026-04-15 Date of stock award to Ellis Gary Lee

Key Terms

Common Stock, Non-Employee Director Compensation Policy, grant/award acquisition, Form 4

4 terms

Common Stock financial

"Represents shares of common stock received in lieu of cash fees"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Non-Employee Director Compensation Policy financial

"pursuant to the Company's Non-Employee Director Compensation Policy"

grant/award acquisition financial

"transaction_action: grant/award acquisition"

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

04/16/2026 - 04:05 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ellis Gary Lee

(Last)

(First)

(Middle)

C/O INSPIRE MEDICAL SYSTEMS, INC.

5500 WAYZATA BLVD., SUITE 1600

(Street)

GOLDEN VALLEY

MINNESOTA

55416

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Inspire Medical Systems, Inc. [ INSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/15/2026		A		518⁽¹⁾	A	$52.07	7,276	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

	/s/ Bryan Phillips, Attorney-in-Fact for Gary L. Ellis	04/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Inspire Medical Systems (INSP) director Ellis Gary Lee report on this Form 4?

Director Ellis Gary Lee reported receiving 518 shares of Inspire Medical Systems Common Stock. The shares were granted as a stock award under the company’s Non-Employee Director Compensation Policy, rather than bought on the open market, and increased his direct holdings.

Was the Inspire Medical Systems (INSP) Form 4 transaction an open-market purchase or a stock grant?

The Form 4 transaction was a stock grant, not an open-market purchase. Ellis Gary Lee received 518 shares valued at $52.07 each as compensation in lieu of cash director fees under the company’s Non-Employee Director Compensation Policy.

How many Inspire Medical Systems (INSP) shares did Ellis Gary Lee hold after this Form 4 transaction?

After the reported transaction, Ellis Gary Lee directly held 7,276 shares of Inspire Medical Systems Common Stock. This total reflects the addition of 518 shares received as a grant in lieu of cash fees, as disclosed in the Form 4 filing.

Why did Ellis Gary Lee receive Inspire Medical Systems (INSP) shares instead of cash?

Ellis Gary Lee received Inspire Medical Systems shares in lieu of cash fees. The footnote explains the 518-share award was made pursuant to the company’s Non-Employee Director Compensation Policy, which allows directors to receive stock instead of cash compensation.

Does this Inspire Medical Systems (INSP) Form 4 indicate any derivative security exercises?

The Form 4 does not show any derivative security exercises. It reports a single non-derivative transaction in Common Stock, where Ellis Gary Lee acquired 518 shares as a grant, and the derivativeSummary section is empty in the provided data.